about
Aquaporin 4 and neuromyelitis opticaGreatly improved neurological outcome after spinal cord compression injury in AQP4-deficient mice.Treatment of neuromyelitis optica: state-of-the-art and emerging therapiesSevere neurologic impairment in mice with targeted disruption of the electrogenic sodium bicarbonate cotransporter NBCe2 (Slc4a5 gene)Safety profile and probe placement accuracy of intraspinal pressure monitoring for traumatic spinal cord injury: Injured Spinal Cord Pressure Evaluation study.A novel and accurate diagnostic test for human African trypanosomiasis.In vivo measurement of brain extracellular space diffusion by cortical surface photobleaching.Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice.Aquaporins: important but elusive drug targets.Pathophysiology of septic encephalopathy: a review.Craniofacial fibrous dysplasia complicated by acute, reversible visual loss: report of two cases.Principles of gene therapy: potential applications in the treatment of cerebral ischaemia.Small-molecule inhibitors of NMO-IgG binding to aquaporin-4 reduce astrocyte cytotoxicity in neuromyelitis optica.Neuromyelitis optica IgG causes placental inflammation and fetal death.Emerging molecular mechanisms of brain tumour oedema.Extracellular space diffusion in central nervous system: anisotropic diffusion measured by elliptical surface photobleachingAquaporin-4 in brain and spinal cord oedema.Aquaporin-4 expression is increased in oedematous human brain tumours.Water transport becomes uncoupled from K+ siphoning in brain contusion, bacterial meningitis, and brain tumours: immunohistochemical case review.Expansion duroplasty improves intraspinal pressure, spinal cord perfusion pressure, and vascular pressure reactivity index in patients with traumatic spinal cord injury: injured spinal cord pressure evaluation study.Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica.Glioblastoma blood flow measured with stable xenon CT indicates tumor necrosis, vascularity, and brain invasionNew insights into water transport and edema in the central nervous system from phenotype analysis of aquaporin-4 null mice.Mildly Reduced Brain Swelling and Improved Neurological Outcome in Aquaporin-4 Knockout Mice following Controlled Cortical Impact Brain Injury.Sporadic obstructive hydrocephalus in Aqp4 null mice.Paucity of natural killer and cytotoxic T cells in human neuromyelitis optica lesions.OMICS and brain tumour biomarkers.Aquaporins and cell migration.Aquaporin-4 and brain edema.Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brainWater movements in the brain: role of aquaporins.Aquaporin water channels in the nervous system.Spinal cord injury: is monitoring from the injury site the future?No association between seniority of surgeon and postoperative recurrence of chronic subdural haematomaAQP4 gene deletion in mice does not alter blood-brain barrier integrity or brain morphology.Experimental mouse model of optic neuritis with inflammatory demyelination produced by passive transfer of neuromyelitis optica-immunoglobulin G.Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain.Delays in treating patients with good grade subarachnoid haemorrhage in London.Natural history of idiopathic normal-pressure hydrocephalus.Systematic review of the outcome of shunt surgery in idiopathic normal-pressure hydrocephalus.
P50
Q24613666-92630764-A8FF-4059-8FA8-02F9F390113CQ27863378-8B8147CE-9E2C-4C5A-A69A-9395B7FB6EC6Q28245749-96289999-80DC-44E1-9CA5-80E4A6A2DF1CQ28511830-0809BE05-D0A2-437A-ADE3-905C8ADC04EBQ31087887-30995A84-3524-4DD4-912D-D2EB832EFD54Q33202345-97C6DE0D-74E5-4290-9DAC-933FDC04AF05Q33206893-61E7B4E7-4ED9-47CD-8C23-BC6919FCA908Q33656297-F2E4DAFC-FC45-479E-8BF7-FFFE93EC4B7EQ33792739-A9D53645-B42D-44AD-BDBA-16F23283931BQ34019242-DBDB5441-17E8-45A5-9A94-CAA7F07CF45DQ34050610-F5102D4E-02D9-4734-9560-6EE7622253EFQ34151858-8AEB4CC2-8756-4CEF-8477-2DC2086AED39Q34154265-0E1C34A0-A2D7-41FB-AD08-94566A6FD0A2Q34168084-49E6C50D-89DB-430B-BA6B-F080C1F2B91FQ34255716-B3FA42DB-50A3-46C2-963A-0A6B5478CAD6Q34351926-78A0934E-ED8B-42A4-85D3-DE7426FE1F15Q34997531-31BF0CA5-D665-4AC4-A8A7-7294421CE1B1Q35465645-806DEB98-4039-40D9-96C6-E38E3D589A1EQ35587195-1F0E3841-385E-4CAA-A765-A5044C993746Q35821877-93CF8547-E2DF-459D-AD4F-B800794A3A7AQ35857869-106F2799-BB70-49E4-AE81-FAAA70E4CE42Q35914515-0F85D133-1846-4F60-B409-75E9C1265C05Q35961506-790FF863-BAC4-4592-89D9-0C22A00DD0D4Q36108495-B737A495-184C-40B7-AB9B-61E445BCD21AQ36638956-21FC7EA9-1FFA-4F5B-AC29-FA2F6D6A61ABQ36661685-F159AE17-33D8-4D01-A10B-D04BC6C98F1DQ36665688-B798AD1B-4B03-4BDF-BE4C-1BF1FA8E40C2Q36677150-A7E01374-E157-4459-AFEE-7259DBEE5E9DQ36755429-79D5E531-C893-4CD3-A7E3-B5A57E3052EBQ36814107-550BF756-4BBE-43AC-90E4-26BA283286E4Q37022430-F32937F3-CC37-4535-8BC2-E57F25A17E42Q37066291-9DFB4ADD-DCD0-4D86-9A93-621B868471E0Q37311183-8F3B2DA1-4C17-4980-A819-885233CC61E4Q37395322-B0BE093E-CC98-42C0-A8C8-7B29D042C6F4Q37433008-1D8F2439-93DE-4D44-AAE6-7C36B58503B4Q37539041-8B9EF2A5-4B80-4640-AFB4-E1DC7B7C91AAQ37688795-6F2B5D3B-CFDC-4F45-987D-A1AEC4CEE34AQ37872314-2391252F-5574-4AFD-A4D9-0AC8B245F995Q37877176-02B2CFD8-DD86-4A9F-8BE5-00B04A01FCF0Q38131454-84D05E0A-B37B-4480-8FC5-CCD69D74C7A5
P50
description
researcher
@en
name
M C Papadopoulos
@en
M C Papadopoulos
@nl
type
label
M C Papadopoulos
@en
M C Papadopoulos
@nl
prefLabel
M C Papadopoulos
@en
M C Papadopoulos
@nl
P106
P31
P496
0000-0001-9174-4176